Clinically reviewed by Dr. Sarah Boss, MD
Remove all rivastigmine patches and obtain urgent medical advice if overdose is suspected. Never apply a new patch without removing the old one. Fainting, severe vomiting, bleeding, a seizure or breathing difficulty needs urgent assessment. Contact the prescriber before restarting after three or more days without treatment.
Rivastigmine is a cholinesterase inhibitor used to manage symptoms of certain dementias. It is available in oral and skin-patch formulations, which have different instructions and may have different licensed indications. The patch can be useful when an oral medicine is difficult to manage, but it introduces a specific safety issue: the old patch must be removed before a new one is applied. Treatment should support meaningful daily goals rather than be presented as a cure.
What rivastigmine is used for
Rivastigmine is used for dementia associated with Alzheimer’s disease and, for relevant products and jurisdictions, Parkinson’s disease. It increases the availability of acetylcholine by inhibiting enzymes that break it down. This can help symptoms of thinking and functioning, but it does not cure the underlying condition. Confirm the diagnosis, stage and actual formulation with the prescriber. [1]
NICE also recommends rivastigmine in selected people with dementia with Lewy bodies, with the relevant off-label distinction explained in its guidance. These recommendations should not be transferred to every cause of memory difficulty. A prescriber should explain why the evidence applies to this person rather than simply describing the product as a memory patch. [2]
Oral treatment and transdermal treatment are not identical
Capsules and patches deliver the same active medicine differently. The amount written on a patch describes a particular delivery system and is not a tablet-equivalence instruction. Switching routes requires the prescriber’s plan. Do not continue an earlier oral supply alongside a new patch unless explicitly instructed, and do not convert doses from an online table.
Ask why the route was chosen. Swallowing problems, gastrointestinal tolerance, adherence and caregiver support may be relevant, but a patch does not automatically solve every administration difficulty. The person still needs a reliable routine and someone able to recognize an error or adverse effect when support is required.
The most important patch rule
Remove the previous patch before applying the next one. Medication errors involving multiple patches or failure to remove an old patch have caused serious adverse reactions, including hospitalization and rare deaths. A patch should not be cut into pieces or used to make a self-selected dose. Follow the product’s specified application sites and replacement schedule. [3]
Keep an application record showing the date, time, site and removal of the previous patch. This is especially important when several relatives or care staff share responsibility. A verbal message that the medicine was given may not establish whether the old patch was removed. Check the record together during a change of caregiver or care setting.
Skin care, heat and a detached patch
Apply the prescribed patch to appropriate clean, dry, healthy skin and rotate sites according to the instructions. Avoid prolonged external heat exposure and do not place it on damaged or irritated skin. If it loosens or falls off, follow the actual product advice rather than adding patches or changing the schedule independently. Used patches should be folded and disposed of safely away from children and pets. [4]
Ask the pharmacist to demonstrate the routine and explain what to do if no one is certain whether a patch was applied. The correct response is not to add another just in case. Keep the packaging and leaflet accessible so a substitute caregiver can identify the product rather than guessing from the patch’s appearance.
Skin irritation versus allergic contact dermatitis
A mild local reaction can occur, but a rash spreading beyond the patch, increasing swelling or blistering, or a reaction that does not improve as expected after removal needs assessment. Product information warns about allergic contact dermatitis. A suspected allergy should not be managed by independently switching to oral rivastigmine; specialist assessment may be needed before further exposure. [5]
Record when the reaction appeared and which sites were used. A photograph may help a clinician compare the area over time, but do not delay advice while documenting it. Severe allergy or breathing difficulty requires emergency help. The need to rotate sites does not mean a significant reaction should simply be moved to another area and ignored.
Nausea, weight loss and hydration
Nausea, vomiting, diarrhea and reduced appetite are important adverse effects. They can lead to dehydration or weight loss, particularly when the person already eats poorly. Report persistent symptoms and changes in fluid intake. A patch may reduce some administration difficulties, but it does not remove all systemic adverse effects. [4]
Keep the record practical: missed meals, vomiting episodes, clothes becoming looser or reduced urine. Ask the clinician how weight and tolerance will be monitored and who should be contacted between appointments. Do not assume that reduced appetite is simply part of dementia or use another person’s anti-nausea medicine without an interaction check.
Heart, breathing and neurological precautions
Rivastigmine can slow heart rate and contribute to fainting. Rhythm problems, asthma or other respiratory disease, seizures, ulcers and urinary problems are relevant to assessment. Fainting, chest pain, a seizure or new breathing difficulty needs urgent review. Black stools or vomiting blood should be treated as possible gastrointestinal bleeding rather than an ordinary digestive side effect. [4]
Tell the clinician about falls and brief blackouts even when the person appears well afterward. Describe the event rather than assuming it was clumsiness. A caregiver may notice symptoms that the person does not recall, so communication between the patient, supporters and prescriber is an important part of monitoring.
Interruptions and restarting
After three or more days without rivastigmine, contact the prescriber before restarting. Retitration may be necessary to reduce serious gastrointestinal and other reactions; do not resume the previous patch or oral regimen by habit. An interruption caused by vomiting, hospital admission or a supply problem should be recorded accurately. [4] [5]
Ask what to do while waiting for advice and whether another medicine was substituted during the interruption. The receiving team should know the last actual administration, not only the date of the most recent prescription. A clear record prevents a routine-looking restart from bypassing an important safety check.
Mental health, behavior and realistic expectations
Dementia can coexist with depression, anxiety, sleep problems or distress. Rivastigmine is not a universal treatment for those conditions or an acute calming medicine. A change in behavior should be assessed for pain, illness, environment and other medication effects. NICE emphasizes looking for causes of distress and maintaining person-centered support rather than responding to every difficulty with a prescription. [2]
Ask what improvement the medicine is intended to produce. Participation in conversation, ability to follow a familiar routine or reduced need for prompting may be meaningful. Avoid repeatedly testing memory in ways that upset the person. Everyday observations and the person’s own preferences should be part of the review.
Interactions and the whole medication list
Other medicines that slow heart rate, treatments with anticholinergic effects and certain movement- or nausea-related drugs may complicate treatment. Inform procedural teams about rivastigmine before anesthesia. Provide non-prescription sleep and cold products as well as regular prescriptions. A patch can be overlooked because it is not in the pill organizer. [5]
Do not stop a heart medicine or psychiatric treatment independently because of a general interaction warning. Ask the pharmacist to reconcile the purposes and risks of the full list. Include the patch’s site and replacement routine in a handover so that hospital or residential-care staff know it is present.
Detox, alcohol and other causes of cognitive symptoms
Rivastigmine is not an alcohol-detox medicine or a substitute for urgent thiamine treatment when Wernicke’s encephalopathy is suspected. Confusion associated with heavy alcohol exposure, malnutrition or acute illness requires assessment for its cause. NICE recommends thiamine in relevant high-risk and suspected cases, with clinical decisions about the route. [6]
Longer-term memory problems in someone with substance-use history should not automatically be labeled Alzheimer’s disease. Describe the history, injuries, nutrition, medicines, mood and sleep. A rehabilitation or addiction-care plan may be needed alongside neurological assessment, rather than an unreviewed trial of a dementia drug.
Stopping, benefit and the meaning of deterioration
Rivastigmine is not normally considered an addictive intoxicant. Changes after stopping should not be described automatically as addiction withdrawal. They may reflect loss of benefit, disease progression or another illness. The decision to continue or stop should consider tolerability, meaningful function, goals and the clinical context. NICE advises against stopping dementia acetylcholinesterase treatment solely on the basis of disease severity. [2]
Agree how a proposed change will be monitored and what would trigger reconsideration. Avoid changing several medicines, routines and care arrangements at once without recording them, because interpreting the result becomes difficult. A planned review respects uncertainty more effectively than an abrupt unobserved experiment.
Building a workable care routine
Choose a daily routine that the person can participate in as much as possible. Clarify who applies the patch, checks removal, records reactions and orders the next supply. Respect privacy when checking application sites and explain what is being done rather than treating medication administration as a task performed around the person.
Review the arrangement when caregivers change or the person moves. A record should include the exact product, the last application and removal, any interruption and the prescriber’s contact. Practical support is part of safe treatment; a stable prescription does not guarantee that administration remains reliable in a new setting.
Frequently asked questions
Can two patches be used to make up a missed day?
No. Do not add extra patches. Follow the product instructions and obtain advice when the administration history is uncertain.
Does the patch treat Parkinson’s movement symptoms?
Its dementia role should not be confused with treatment of Parkinson’s motor symptoms. The precise licensed indication varies by product and country. Ask which symptoms are being targeted.
What should I do after several days without treatment?
Contact the prescriber before restarting. The previous regimen may need to be reintroduced differently, even if the person tolerated it before the interruption.
